Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2009 A Novel Strategy for a Cocktail 18F Fluoride and 18F FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot Phase Study. J Nucl Med. 2009 Apr;50(4):501-505.
2. 2009 18F FDG PET/CT in Cancers of the Head and Neck: What is the Definition of Whole-Body Scanning submitted)
3. 2009 Diagnosis please. Radiology 2009 (in press)
4. 2009 131I-Tositumomab (Bexxar®) vs. 90Y-Ibritumomab (Zevalin®) Therapy of Refractory/Relapsed Non-Hodgkin Lymphoma Eur J Nucl Med Mol Imaging. 2009 Jul 8. [Epub ahead of print
5. 2009 131I-Tositumomab (Bexxar®) vs. 90Y-Ibritumomab (Zevalin®) Therapy of Refractory/Relapsed Non-Hodgkin Lymphoma Mol Imaging Biol. 2009 Jun 20. [Epub ahead of print]
6. 2009 Tumor Metabolic Phenotypes on 18F FDG PET. J Nucl Med. 2009 May 14. [Epub ahead of print]
7. 2009 Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization. J Vasc Interv Radiol. 2009 May;20(5):606-13.
8. 2009 Evaluation by 18F FDG PET of patients with anal squamous cell carcinoma. Hell J Nucl Med. 2009 Jan-Apr;12(1):26-8.
9. 2008 Perspectives of Molecular Imaging and Radioimmunotherapy in Lymphoma. Perspectives of Molecular Imaging and Radioimmunotherapy in Lymphoma.
10. 2008 18F FDG PET/CT Evaluation of Response to Therapy in Lymphoma: When is the Optimal Time for the First Re-evaluation Scan? Hell J Nucl Med. 2008 Sep-Dec;11(3):153-6.
11. 2008 18F FDG PET/CT Evaluation of Patients with Ovarian Carcinoma Nucl Med Commun. 2008 Dec;29(12):1046-51.
12. 2008 Novel techniques in breast imaging. US Radiology. 2008 1(1):47-55.
13. 2008 90Y-Ibritumomab (Zevalin®) Therapy in Refractory Non-Hodgkin s Lymphoma: Observations from 111In-Ibritumomab Pre-Treatment Imaging. J Nucl Med. 2008 Nov;49(11):1809-1812
14. 2008 Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by 18F FDG PET/CT and bone marrow biopsy. Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1746.
15. 2008 123I MIBG Mapping with Intraoperative Gamma Probe for Recurrent Neuroblastoma. Mol Imaging Biol. 2008 Jan-Feb;10(1):19-23.
16. 2007 Follicular Dendritic Sarcoma within a Focus of Castleman s Disease. Serial 18F FDG PET/CT in the Follow-Up of Recurrence with Histopathologic Confirmation Rev Esp Med Nucl. 2007 Jan;26(1):40-5.
17. 2007 18F FDG PET and PET/CT Evaluation of Response to Neoadjuvant Chemotherapy in Musculoskeletal and Soft-Tissue Sarcomas. Clin Clin Nucl Med. 2008 Jan;33(1):8-13
18. 2007 PET Imaging of Skull Base Neoplasms PET Clinics. 2007 Oct;2(4):489-510
19. 2007 Molecular Imaging Can Speed Up Anti-Angiogenic Drug Development. Nat Clin Pract Oncol. 2007 Oct;4(10):556-7.
20. 2007 18F FDG PET/CT in the Management of Thyroid Cancer Clin Nucl Med. 2007 Sep;32(9):690-5.
21. 2007 Advances in Metabolic Imaging for Surgical Oncology. Surg Oncol Clin N Am. 2007 Apr;16(2):273-92.
22. 2007 Detection of Occult Medullary Thyroid Cancer Recurrence with 18F FDG PET and PET/CT Mol Imaging Biol. 2007 Mar-Apr;9(2):72-7.
23. 2007 Therapy of Thyrotoxicosis. J Nucl Med. 2007 Mar;48(3):379-89.
24. 2007 18F FDG PET Visualization of Urinary Leak Following Nephrostomy Tube Removal. Clin Nucl Med. 2007 Feb;32(2):168-169.
25. 2007 Breast MRI and 18F FDG PET/CT in the Management of Breast Cancer. Ann Nucl Med. 2007 Jan;21(1):33-8.
26. 2007 18F FDG PET/CT in the Management of Melanoma. Mol Imaging Biol. 2007 Jan-Feb;9(1):50-7
27. 2007 18F FDG PET/CT Demonstration of an Adrenal Metastasis in a Patient with Anaplastic Thyroid Cancer Clin Nucl Med. 2007 Jan;32(1):13-5.
28. 2006 Iagaru A, Chawla SP, Menendez LR, Conti PS. Clin Nucl Med. 2006 Dec;31(12):754-760.
29. 2006 18F FDG PET and PET/CT for Detection of Pulmonary Metastases from Musculoskeletal Sarcomas. Nucl Med Commun. 2006 Oct;27(10):795-802.
30. 2006 18F FDG PET and PET/CT Diagnosis of Patients with Recurrent Papillary Thyroid Cancer. Mol Imaging Biol. 2006 Sep-Oct;8(5):309-14.
31. 2006 Ectopic Mediastinal Parathyroid Adenoma on 99mTc Sestamibi Myocardial Perfusion Scintigraphy. J Nucl Cardiol. 2006 Sep;13(5):719-21.
32. 2006 18F FDG PET/CT in the Follow-Up of Non-Ossifying Fibroma. AJR Am J Roentgenol. 2006. Sep;187(3):830-2.
33. 2006 18F FDG PET Imaging of Urinary Bladder Oat Cell Carcinoma with Widespread Osseous Metastases Clin Nucl Med. 2006 Aug;31(8):476-8.
34. 2006 Merkel Cell Carcinoma: Is There a Role for 18F FDG PET/CT? Mol Imaging Biol. 2006 Jul-Aug;8(4):212-7.
35. 2006 18F FDG PET Evaluation of Bronchial Plasmacytoma, with CT and MRI Correlation. Clin Nucl Med. 2006 May;31(5):279-80.
36. 2006 Demonstration of a Right Inguinal Hernia Containing Urinary Bladder Diverticulum on Whole Body Bone Scan and Pelvic CT Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):234
37. 2005 Failed Atrial Septal Defect Repair versus Pulmonary Hypertension with Right Ventricular Failure. Clin Nucl Med. 2005 Nov;30(11):767-8.
38. 2005 18F FDG PET/CT Demonstration of Salivary Glands Involvement in Sjogren s Syndrome Clin Nucl Med. 2005 Oct;30(10):698-9.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.